Ankit Jain, CEO and co-founder of Infinitus, outlined a vision for AI-driven patient access at Access USA today, arguing that healthcare organizations are misusing personnel by assigning them tasks readily handled by artificial intelligence. Jain’s remarks, previewed in a conversation with Pharmaceutical Executive, center on a shift in focus toward empathetic patient care, enabled by automating administrative burdens.
Infinitus aims to streamline the patient journey from initial diagnosis through therapy adherence, a process Jain described as often fraught with anxiety and logistical hurdles. According to Jain, a significant percentage of diagnosed patients do not ultimately commence appropriate therapies, and even fewer maintain adherence over time. The company’s approach targets friction points such as prior authorization and benefit verification.
“Most groups are using their people the wrong way,” Jain stated. “Most people, most groups, are using their people to do function that AI can do although they have to because of a lack of resources, neglect the work that really gets the patient that empathetic care at a time of extreme need.”
Infinitus’s model envisions AI handling repetitive tasks – including benefit verification, initial patient contact, and data collection – freeing up case managers and patient navigators to focus on direct patient support. The company reports having completed over 100 million minutes of autonomous conversations, demonstrating the potential for accelerated therapy initiation.
Jain addressed concerns surrounding AI implementation in healthcare, acknowledging the industry’s cautious approach to new technologies. He noted a common pattern of organizations waiting for others to demonstrate proof of concept and repeatability before adopting new solutions. Infinitus, he said, has been developing this technology for the past seven years.
“There’s a lot that goes into earning trust from healthcare organizations looking to use AI,” Jain explained. “No one wants to be the first one to adopt a new technology. Everyone wants to be number three.”
The Infinitus approach emphasizes a collaborative relationship between humans and AI, with human oversight guiding AI systems and AI continuing processes when human staff are occupied with other tasks. This hybrid model, Jain argues, accelerates patient access to therapy, reduces frustration for healthcare providers, and ensures pharmaceutical products achieve their intended impact.
Infinitus, founded by Jain, is based in San Francisco and is backed by investors, according to the company’s website. Jain also discussed his vision for the company’s impact on healthcare in a recent interview with Fierce Pharma.
Leave a Reply